← All trials
NCT04452565
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 15, 2020
- Primary completion
- Dec 31, 2020
- Completion date
- Feb 15, 2021
- First posted
- Jun 30, 2020
- Last posted
- Sep 7, 2020
- Enrollment
- 525
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- NeuroActivaLead sponsor
- NeuroActivaStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.